Background
==========

Lung cancer is the most common and lethal cancer worldwide, with an estimated 1.8 million new cases and 1.6 million deaths from this disease in 2012 \[[@b1-medscimonit-24-5771]\]. In China, there were approximately 610 000 deaths due to lung cancer in 2015 \[[@b2-medscimonit-24-5771]\]. Lung cancer has become a serious public health challenge and although research has focussed on developing new drug and treatment modalities for decades, the prognosis of lung cancer patients with recurrence or metastasis remains very poor.

Smoking is considered to the major risk factor for lung cancer \[[@b3-medscimonit-24-5771]\]. However, only a small proportion of female lung adenocarcinoma patients are associated with smoking \[[@b4-medscimonit-24-5771],[@b5-medscimonit-24-5771]\]. Molecular-level studies have indicated that some genes are correlated with lung adenocarcinoma in never-smokers, such as RET \[[@b6-medscimonit-24-5771]\], EGFR \[[@b7-medscimonit-24-5771]\], SEMA5A \[[@b8-medscimonit-24-5771]\], PIK3CA \[[@b9-medscimonit-24-5771]\], and KRAS \[[@b10-medscimonit-24-5771]\]. In addition, the molecular mechanisms of tumorigenesis in female lung cancer patients remain unclear. lncRNAs, a class of RNA molecules, 200 to hundreds of thousands of nucleotides long, are deregulated in a variety of diseases and are involved in various biological processes \[[@b11-medscimonit-24-5771]--[@b14-medscimonit-24-5771]\]. To date, however, little is known about the roles of lncRNAs in non-smoking female lung cancer.

In this study, the microarray data (GSE19804, GSE31210, and GSE31548) were obtained from the Gene Expression Omnibus (GEO, *<http://www.ncbi.nlm.nih.gov/geo>*) database. Then, we determined the differentially expressed genes (DEGs) by using bioinformatics analysis. Furthermore, target miRNAs of differentially expressed lncRNAs and target mRNAs corresponding to miRNAs were predicted. Subsequently, the interaction network among lncRNAs, miRNAs and mRNAs were constructed in non-smoking female lung cancer. This study can promote our understanding of the role of lncRNAs and associated pathways in non-smoking female lung cancer.

Material and Methods
====================

Microarray data
---------------

Three gene expression profiles (GSE19804, GSE31210, and GSE31548) were obtained from the Gene Expression Omnibus (GEO, *<http://www.ncbi.nlm.nih.gov/geo>*) database. GSE19804 and GSE31210 datasets were based on Affymetrix Human Genome U133 Plus 2.0 Array, and GSE31548 dataset was performed by Affymetrix Human Genome U133B Array. The array data of GSE19804 included 60 non-smoking female lung cancer tissue samples and 60 non-smoking healthy female lung tissues \[[@b8-medscimonit-24-5771]\]. GSE31210 contained 246 samples, consisting of 98 never-smoking female lung cancer samples and 4 normal female lung tissues \[[@b15-medscimonit-24-5771]\]. GSE31548 contained 50 samples, including 6 never-smoking female lung cancer samples and 5 normal female lung tissues.

Identification of differentially expressed genes
------------------------------------------------

The GEO2R (*<http://www.ncbi.nlm.nih.gov/geo/geo2r/>*) was used to identify differentially expressed genes (DEGs) between lung cancer and normal samples. GEO2R is an interactive web analysis tool based on R that comes with the GEO database and can analyze almost all GEO data. The *P* value was adjusted (adj. *P*) with Benjamini and Hochberg method by default to obtain false discovery rate (FDR). The absolute fold change (\|logFC\|) \>1 and adj. *P*\<0.05 were set as the cut-off criterion. The gplots package was used to generate the heat maps under the R environment (version 3.3.4, *<https://www.r-project.org/>*).

Construction of lncRNA-miRNA-mRNA ceRNA network
-----------------------------------------------

The lncRNA-miRNA-mRNA ceRNA network was constructed to explore the association among lncRNA, miRNA, and mRNA based on the hypothesis of ceRNA \[[@b16-medscimonit-24-5771]\]. The target miRNAs of the differentially expressed lncRNAs were predicted using miRNA tools miRecords (*<http://www.microrna.org>*) and starBase v2.0 database (*<http://starbase.sysu.edu.cn/>*) \[[@b17-medscimonit-24-5771],[@b18-medscimonit-24-5771]\]. The mRNAs targeted by miRNAs were predicted by miRecords and starBase v2.0 database, and then the predicted results and DEGs of GSE19804, GSE31210, and GSE31548 datasets were combined to gain the intersection mRNAs. Subsequently, the ceRNA network was established and visualized using Cytoscape (v3.40) software. The intersection mRNAs were determined by pathway enrichment analysis using the DAVID database (*<http://david.abcc.ncifcrf.gov/>*) \[[@b19-medscimonit-24-5771]\].

Survival analysis of differentially expressed lncRNAs
-----------------------------------------------------

Kaplan-Meier Plotter (*<http://kmplot.com/analysis/>*) is a public online database that can assess the relationship between many genes and breast or ovarian or lung or gastric cancer patient survival \[[@b20-medscimonit-24-5771]\]. This database comprises clinical information and gene expression data for 2437 lung cancer patients. The overall survival (OS) of non-smoking female lung cancer was detected by a Kaplan-Meier plot. Hazard ratio (HR) and its 95% confidence intervals (CI) were computed and displayed on the page. *P*\<0.05 was considered statistically significant.

Results
=======

Differentially expressed lncRNAs in non-smoking female lung cancer patients
---------------------------------------------------------------------------

A total of 25, 40, and 15 differentially expressed lncRNAs were identified from GSE19804, GSE31210, and GSE31548 datasets (\|logFC\| \>1, adj. *P*\<0.05), respectively ([Figure 1](#f1-medscimonit-24-5771){ref-type="fig"}). Eight lncRNAs were screened out in all 3 datasets ([Figure 2](#f2-medscimonit-24-5771){ref-type="fig"}). Among them, 5 lncRNAs (*AFAP1-AS1*,*LINC00467*, *LINC00511*, *LINC00673* and *LINC01207*) were up-regulated and 3 lncRNAs (*LINC00472*, *LINC00968*, and *TBX5-AS1*) were down-regulated in lung cancer tissues compared to non-tumor lung tissues ([Figure 2](#f2-medscimonit-24-5771){ref-type="fig"}, [Table 1](#t1-medscimonit-24-5771){ref-type="table"}).

Prediction of lncRNA targets and ceRNA network construction
-----------------------------------------------------------

To construct the ceRNA network, miRecords and starBase v2.0 were used to detect the potential target miRNAs \[[@b17-medscimonit-24-5771],[@b18-medscimonit-24-5771]\]. The results indicated 10 aberrantly expressed lncRNAs targeted by 20 specific miRNAs ([Table 2](#t2-medscimonit-24-5771){ref-type="table"}). In the next step, based on miRecords and starBase v2.0, the predicted targets of miRNAs described in [Table 2](#t2-medscimonit-24-5771){ref-type="table"} were gained. Subsequently, the predicted results and DEGs were combined to obtain the intersection mRNAs. We identified the targeted relationship between 19 specific miRNAs and the 38 intersection mRNAs ([Table 3](#t3-medscimonit-24-5771){ref-type="table"}). Of these, some targets are cancer-related genes, such as RECK, EZH2, LATS2, CXCL12, NR4A2, TPPP3. Next, based on the data described in [Tables 2](#t2-medscimonit-24-5771){ref-type="table"} and [3](#t3-medscimonit-24-5771){ref-type="table"}, the ceRNA network among lncRNA, miRNA, and mRNA was constructed ([Figure 3](#f3-medscimonit-24-5771){ref-type="fig"}). A total of 8 lncRNAs, 19 miRNAs, and 38 mRNAs were involved in the ceRNA network.

Functional and pathway enrichment analysis
------------------------------------------

To learn more about the function of identified intersection DEGs in [Table 3](#t3-medscimonit-24-5771){ref-type="table"}, functional and pathway analysis was carried out using DAVID \[[@b19-medscimonit-24-5771]\]. These genes were mainly enriched in biological processes associated with protein binding, nucleus, metal ion binding, regulation of transcription from RNA polymerase II promoter, nucleic acid binding, cell differentiation, microRNAs in cancer, and hippo signaling pathway ([Table 4](#t4-medscimonit-24-5771){ref-type="table"}).

Kaplan-Meier plotter identified potential prognostic lncRNAs for never-smoking female lung cancer
-------------------------------------------------------------------------------------------------

We used Kaplan-Meier plotter to assess the prognostic values of the 8 lncRNAs in never-smoking female lung cancer patients \[[@b20-medscimonit-24-5771]\]. *P* value less than 0.05 was considered a significant statistical difference. The results showed that only low LINC00968 (HR=0.24, 95%CI: 0.08--0.74, *P*=0.0067) and TBX5-AS1 (HR=0.19, 95% CI: 0.05--0.64, *P*=0.0028) expression were related to unfavorable prognosis in never-smoking female lung cancer patients ([Figure 4](#f4-medscimonit-24-5771){ref-type="fig"}). However, there was no significant relationship among the expressions of other lncRNAs and prognosis of non-smoking female lung cancer.

Discussion
==========

In this study, we first analyzed the microarray data of non-smoking female lung cancer from GEO database under the accession number GSE19804, GSE31210, and GSE31548 by GEO2R to obtain the DEGs. GEO2R is a powerful tool to process gene expression data and can analyze almost all GEO data. Then, the target miRNAs of these lncRNAs and the mRNAs targeted by miRNAs were predicted. Finally, the lncRNAs-miRNAs-mRNAs ceRNA network was constructed. This study provides important clues for exploring the key lncRNAs and associated regulatory network in pathogenesis of non-smoking female lung carcinoma.

According to our results, a total of 8 differentially expressed lncRNAs including 5 up-regulated lncRNAs and 3 down-regulated lncRNAs were identified in all 3 datasets. Among them, lncRNAs *AFAP1-AS1*,*LINC00467*, *LINC00511*, *LINC00673,* and *LINC01207* were significantly up-regulated, and*LINC00472*, *LINC00968*, and *TBX5-AS1* were significantly down-regulated in female lung cancer tissue in this study. Sui et al. analyzed the RNA sequencing data in 521 lung adenocarcinoma tissues and 49 non-tumor lung tissues from The Cancer Genome Atlas (TCGA) (*<http://cancergenome.nih.gov/>*), showing that *AFAP1-AS1* was over-expressed and *LINC00472* were under-expressed in lung cancer tissues compared to normal lung tissues \[[@b21-medscimonit-24-5771]\]. Recently, some studies reported that*AFAP1-AS1, LINC00511, LINC00673,* and *LINC01207* are up-regulated in lung cancer tissues, and promote cell proliferation, invasion, and metastasis \[[@b22-medscimonit-24-5771]--[@b27-medscimonit-24-5771]\]. Similarly, these lncRNAs were also involved in tumorigenesis and tumor progression and prognosis of other cancers \[[@b28-medscimonit-24-5771]--[@b34-medscimonit-24-5771]\]. Together, these results suggest that these aberrantly expressed lncRNAs play key roles in tumorigenesis and development of non-smoking female lung carcinoma. Furthermore, some other differentially expressed lncRNAs also related to the pathogenesis of cancers, such as enhanced LINC00467 expression, can promote neuroblastoma cell survival and reduced cell apoptosis \[[@b35-medscimonit-24-5771]\]. Although we found *LINC00968* and *TBX5-AS1* were decreased in tumor tissue, the biological functions of*LINC00968* and *TBX5-AS1* in lung cancer or other carcinomas remain unclear. We reasonably surmise that these aberrantly expressed lncRNAs play important roles in initiation and development of female lung cancer.

The lncRNAs-miRNAs-mRNAs ceRNA network included 38 aberrantly expressed mRNAs. Functional and pathway enrichment analysis showed that the deregulated lncRNAs were associated with protein binding, metal ion binding, regulation of transcription from RNA polymerase II promoter, nucleic acid binding, microRNAs in cancer, cell differentiation, and hippo signaling pathway. Some cancer-related genes were found in the ceRNA network, such as LATS2 \[[@b36-medscimonit-24-5771]\], EZH2\[[@b37-medscimonit-24-5771]\], RECK \[[@b38-medscimonit-24-5771]\] and NR4A2 \[[@b39-medscimonit-24-5771]\], which were also correlated to the initiation and development of female lung cancer.

Conclusions
===========

We identified aberrantly expressed key lncRNAs from the GEO database and constructed the lncRNA-miRNA-mRNA ceRNA network in non-smoking female lung cancer. Our results provide novel clues to understand the molecular mechanism of the pathogenesis of non-smoking female lung cancer and detect potential prognostic and diagnostic biomarkers. However, further molecular biological experiments are needed to confirm our findings.
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###### 

Differentially expressed lncRNAs in datasets GSE19804, GSE31210 and GSE31548.

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  GEO accession   Number   lncRNAs
  --------------- -------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  GSE19804\       8        AFAP1-AS1, LINC00467, LINC00472, LINC00511, LINC00673, LINC00968, LINC01207, TBX5-AS1
  GSE31210\                
  GSE31548                 

  GSE19804\       6        FENDRR, LINC00341, LINC00622, SYNE3, TINCR, WASIR2
  GSE31210                 

  GSE19804\       1        RNF157-AS1
  GSE31548                 

  GSE19804        10       BRE-AS1, DRAIC, EP300-AS1, HOXB-AS3, LCAL1, LINC00312, LINC00551, LINC01140, MAGI2-AS3, MBNL1-AS1

  GSE31210        26       ADAMTS9-AS1, BDNF-AS, DEPDC1-AS1, FLVCR1-AS1, H1FX-AS1, LAMTOR5-AS1, LINC00115, LINC00638, LINC00689, LINC00702, LINC00842, LINC00857, LINC00944, LINC00961, LINC01106, LINC01123, LINC01314, LINC01569, MAFG-AS1, RALY-AS1, SBF2-AS1, STK24-AS1, STK4-AS1, SYNPR-AS1, THUMPD3-AS1, TMEM51-AS1

  GSE31548        6        ATP13A4-AS1, HAGLR, LINC01088, LINC01279, PAX8-AS1, PAXIP1-AS1
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

miRNAs that may interact with specific lncRNAs.

  lncRNAs       miRNAs
  ------------- ----------------------------------------------------------------------------------------------
  *AFAP1-AS1*   hsa-miR-451a
  *LINC00511*   hsa-miR-29c-3p, hsa-miR-29a-3p, hsa-miR-29b, hsa-miR-16-5p, hsa-miR-15b
  *LINC00467*   hsa-miR-18a-5p, hsa-miR-18b-5p
  *TBX5-AS1*    hsa-miR-92b-3p
  *LINC00472*   hsa-miR-196a, hsa-miR-23a-3p, hsa-miR-302d-3p, hsa-miR-372-3p, hsa-miR-23b-3p,hsa-miR-204-5p
  *LINC00673*   hsa-miR-150-5p, hsa-miR-1231
  *LINC00968*   hsa-miR-26a-5p
  *LINC01207*   hsa-miR-18

###### 

miRNAs targeting specific mRNAs.

  miRNAs            mRNAs
  ----------------- --------------------------------------
  hsa-miR-15b       RECK, WEE1, CACUL1, IPO7
  hsa-miR-16-5p     CADM1,RECK,TPPP3, SPDEF
  hsa-miR-18        CTGF, TIMP3
  hsa-miR-18a-5p    CTGF
  hsa-miR-18b-5p    TIMP3
  hsa-miR-196a      ANXA1,S100A9
  hsa-miR-204-5p    SPDEF, AP1S2
  hsa-miR-23a-3p    CXCL12, ZNF138
  hsa-miR-23b-3p    PLAU
  hsa-miR-26a-5p    EZH2, TGFBR2
  hsa-miR-29a-3p    COL3A1, TET3
  hsa-miR-29b       COL1A1, COL3A1
  hsa-miR-29c-3p    COL1A1, TET3
  hsa-miR-302d-3p   KLF13, NR4A2
  hsa-miR-372-3p    KLF13, LATS2, NR4A2, RECK
  hsa-miR-451a      ABCB1, OSR1
  hsa-miR-92b-3p    CDKN1C
  hsa-miR-150-5p    ZEB1, MYB, gag-pol, MUC4, EGR2, PFN2
  hsa-miR-1231      AZIN1, ZAK, FAM127B, G3BP1, CTGF

###### 

Functional and pathway enrichment analysis analysis of miRNA target genes in ceRNA network.

  Category           Term          Description                                                            Count   *P* value
  ------------------ ------------- ---------------------------------------------------------------------- ------- -----------
  GOTERM_BP_DIRECT   GO: 0030154   Cell differentiation                                                   6       0.002
  GOTERM_BP_DIRECT   GO: 0000122   Negative regulation of transcription from RNA polymerase II promoter   7       0.002
  GOTERM_BP_DIRECT   GO: 0045944   Positive regulation of transcription from RNA polymerase II promoter   8       0.003
  GOTERM_CC_DIRECT   GO: 0005615   Extracellular space                                                    9       0.002
  GOTERM_CC_DIRECT   GO: 0005634   Nucleus                                                                19      0.002
  GOTERM_CC_DIRECT   GO: 0005576   Extracellular region                                                   8       0.022
  GOTERM_MF_DIRECT   GO: 0005515   Protein binding                                                        30      5.0 E-5
  GOTERM_MF_DIRECT   GO: 0046872   Metal ion binding                                                      10      0.018
  GOTERM_MF_DIRECT   GO: 0003676   Nucleic acid binding                                                   6       0.045
  KEGG_PATHWAY       hsa05206      MicroRNAs in cancer                                                    6       0.001
  KEGG_PATHWAY       hsa04390      Hippo signaling pathway                                                3       0.027
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